Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment
Abstract Once reserved for the fittest, worldwide altitude travel has become increasingly accessible for ageing and less fit people. As a result, more and more individuals with varying degrees of respiratory conditions wish to travel to altitude destinations. Exposure to a hypobaric hypoxic environm...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-05-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-022-01979-z |
| _version_ | 1818203651706978304 |
|---|---|
| author | Kirsten Holthof Pierre-Olivier Bridevaux Isabelle Frésard |
| author_facet | Kirsten Holthof Pierre-Olivier Bridevaux Isabelle Frésard |
| author_sort | Kirsten Holthof |
| collection | DOAJ |
| description | Abstract Once reserved for the fittest, worldwide altitude travel has become increasingly accessible for ageing and less fit people. As a result, more and more individuals with varying degrees of respiratory conditions wish to travel to altitude destinations. Exposure to a hypobaric hypoxic environment at altitude challenges the human body and leads to a series of physiological adaptive mechanisms. These changes, as well as general altitude related risks have been well described in healthy individuals. However, limited data are available on the risks faced by patients with pre-existing lung disease. A comprehensive literature search was conducted. First, we aimed in this review to evaluate health risks of moderate and high terrestrial altitude travel by patients with pre-existing lung disease, including chronic obstructive pulmonary disease, sleep apnoea syndrome, asthma, bullous or cystic lung disease, pulmonary hypertension and interstitial lung disease. Second, we seek to summarise for each underlying lung disease, a personalized pre-travel assessment as well as measures to prevent, monitor and mitigate worsening of underlying respiratory disease during travel. |
| first_indexed | 2024-12-12T03:28:44Z |
| format | Article |
| id | doaj.art-69ec5eba8be14f2d89a43b752bf3b025 |
| institution | Directory Open Access Journal |
| issn | 1471-2466 |
| language | English |
| last_indexed | 2024-12-12T03:28:44Z |
| publishDate | 2022-05-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pulmonary Medicine |
| spelling | doaj.art-69ec5eba8be14f2d89a43b752bf3b0252022-12-22T00:39:58ZengBMCBMC Pulmonary Medicine1471-24662022-05-0122111210.1186/s12890-022-01979-zUnderlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessmentKirsten Holthof0Pierre-Olivier Bridevaux1Isabelle Frésard2Service de pneumologie, Centre Hospitalier du Valais RomandService de pneumologie, Centre Hospitalier du Valais RomandService de pneumologie, Centre Hospitalier du Valais RomandAbstract Once reserved for the fittest, worldwide altitude travel has become increasingly accessible for ageing and less fit people. As a result, more and more individuals with varying degrees of respiratory conditions wish to travel to altitude destinations. Exposure to a hypobaric hypoxic environment at altitude challenges the human body and leads to a series of physiological adaptive mechanisms. These changes, as well as general altitude related risks have been well described in healthy individuals. However, limited data are available on the risks faced by patients with pre-existing lung disease. A comprehensive literature search was conducted. First, we aimed in this review to evaluate health risks of moderate and high terrestrial altitude travel by patients with pre-existing lung disease, including chronic obstructive pulmonary disease, sleep apnoea syndrome, asthma, bullous or cystic lung disease, pulmonary hypertension and interstitial lung disease. Second, we seek to summarise for each underlying lung disease, a personalized pre-travel assessment as well as measures to prevent, monitor and mitigate worsening of underlying respiratory disease during travel.https://doi.org/10.1186/s12890-022-01979-zChronic lung diseaseHigh altitude travelAir travelExercise performancePrediction toolsHypoxic tests |
| spellingShingle | Kirsten Holthof Pierre-Olivier Bridevaux Isabelle Frésard Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment BMC Pulmonary Medicine Chronic lung disease High altitude travel Air travel Exercise performance Prediction tools Hypoxic tests |
| title | Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment |
| title_full | Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment |
| title_fullStr | Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment |
| title_full_unstemmed | Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment |
| title_short | Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment |
| title_sort | underlying lung disease and exposure to terrestrial moderate and high altitude personalised risk assessment |
| topic | Chronic lung disease High altitude travel Air travel Exercise performance Prediction tools Hypoxic tests |
| url | https://doi.org/10.1186/s12890-022-01979-z |
| work_keys_str_mv | AT kirstenholthof underlyinglungdiseaseandexposuretoterrestrialmoderateandhighaltitudepersonalisedriskassessment AT pierreolivierbridevaux underlyinglungdiseaseandexposuretoterrestrialmoderateandhighaltitudepersonalisedriskassessment AT isabellefresard underlyinglungdiseaseandexposuretoterrestrialmoderateandhighaltitudepersonalisedriskassessment |